Menu
WP9 will focus on communicating the iCARE4CVD’s progress and results to
everyone that can benefit from our novel research. By facilitating effective
patient-engagement and two-way communication, WP9 provides a
platform for the patient voice within iCARE4CVD.
Through collecting patient feedback and aiding dialogue between patients
and the project, WP9 ensures we follow a patient-centric approach.
Moreover, we will develop a strategic communication and dissemination
plan that delivers tailored messages to all other key target audiences the
project aims to connect with, such as industry, health care professionals,
regulatory authorities, researchers, and citizens. In doing so, WP9 lays the
foundation for future exploitation of project outputs such as the federated
database and novel decision tools.
Subscribe to our newsletter to stay up to date with all the most recent information about iCARE4CVD.
This project is supported by the Innovative Health Initiative Joint Undertaking (IHI JU) and Breakthrough T1D under grant agreement No 101112022. The JU receives support from the European Union’s Horizon Europe research and innovation programme and COCIR, EFPIA, Vaccines Europe, EuropaBio and MedTech Europe.
Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the aforementioned parties. Neither of the aforementioned parties can be held responsible for them.
